SAN DIEGO, Sept. 1, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced James Levine, President and Chief Executive Officer, will present at two upcoming conferences.
Mr. Levine will present at the upcoming Rodman & Renshaw Annual Global Investment Conference on Monday, September 12, 2011. The presentation is expected to begin at 1:35 p.m. ET and will take place at the Waldorf=Astoria Hotel in New York City.
Mr. Levine will also present at the upcoming Wedbush 2011 Clean Technology & Industrial Growth Conference on Thursday, September 15, 2011. The presentation is expected to begin at 3:00 p.m. PT and will take place at The Westin in San Francisco, California.
Live webcasts of both presentations may be accessed by visiting the "Investors" section of Verenium's website at www.verenium.com. A webcast replay will be available approximately one hour after the live webcasts end and will be accessible for 30 days following these conferences.
About VereniumVerenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes. Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets. Read more at www.verenium.com.
Forward-Looking StatementsStatements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty. These include, but are not limited to, statements related to Verenium's lines of business, operations, capabilities, commercialization activities, corporate
|SOURCE Verenium Corporation|
Copyright©2010 PR Newswire.
All rights reserved